Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.295 USD | +7.64% | +11.20% | -54.14% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.14% | 338M | |
+4.50% | 111B | |
+11.11% | 105B | |
-12.28% | 22.34B | |
-3.81% | 21.93B | |
-6.17% | 18.59B | |
-35.21% | 18.12B | |
-9.81% | 16.96B | |
+2.94% | 13.7B | |
+36.31% | 12.45B |
- Stock Market
- Equities
- AVXL Stock
- News Anavex Life Sciences Corp.
- Anavex Life Sciences Begins European Marketing Authorization Process for Blarcamesine to Treat Alzheimer's Disease